"CANCERS 2019 10.3390/cancers11111721
Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study
Yoon1, JS; Sinn, DH; Lee, JH; Kim, HY; Lee, CH; Kim, SW; Lee, HY; Nam, JY; Chang, Y; Lee, YB; Cho, EJ; Yu, SJ; Kim, HC; Chung, JW; Kim, YJ; Yoon, JH
J GASTROEN HEPATOL 2019 10.1111/jgh.14750
Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia
Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
J CLIN MED 2019 10.3390/jcm8101600
The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients
Yoon1, EL; Kim, TY; Song, D; Kim, HY; Kim, CW; Jung, YK; Sinn, DH; Jang, JY; Kim, MY; Jeong, SW; Kim, SG; Suk, KT; Kim, DJ; Han, BH; Lee, BS; Lee, CH; Chae, HB; Kwon, HC; Lee, HJ; Kim, HS; Cho, HC; Yim, HJ; Kim, JH; Suh, JI; Yang, JM; Sohn, JH; Lee, SS; Nam, SW; Park, SH; Baik, SK; Kim, SE; Kim, TH; Choe, WH; Kim, YS
CANCERS 2019 10.3390/cancers11091295
Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study
Chang1, Y; Cho, Y; Lee, JH; Lee, YB; Cho, EJ; Yu, SJ; Sinn, DH; Kim, BH; Kim, SH; Yi, NJ; Lee, KW; Kim, JM; Park, JW; Kim, YJ; Yoon, JH; Joh, JW; Suh, KS
J GASTROEN HEPATOL 2019 10.1111/jgh.14856
Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
Sinn1, DH; Kang, D; Chang, Y; Ryu, S; Cho, SJ; Paik, SW; Song, YB; Pastor-Barriuso, R; Guallar, E; Cho, J; Gwak, GY
EUR J ENDOCRINOL 2019 10.1530/EJE-19-0143
Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study
Sinn1, DH; Kang, D; Choi, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
J GASTROINTEST SURG 2019 10.1007/s11605-018-04074-z
Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
Kim1, JM; Kwon, CHD; Joh, JW; Yoo, H; Kim, K; Sinn, DH; Choi, GS; Lee, JH
J VIRAL HEPATITIS 2019 10.1111/jvh.13185
The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria
Sinn1, DH; Kim, SE; Kim, BK; Kim, JH; Choi, MS
BMC CANCER 2019 10.1186/s12885-019-5740-z
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Yoon1, JS; Song, BG; Lee, JH; Lee, HY; Kim, SW; Chang, Y; Lee, YB; Cho, EJ; Yu, SJ; Sinn, DH; Kim, YJ; Lee, JH; Yoon, JH
EUR RADIOL 2019 10.1007/s00330-018-5868-2
Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure
Cha1, DI; Kang, TW; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Kim, K
BMC CANCER 2019 10.1186/s12885-019-5508-5
Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study
Sinn1, DH; Kang, D; Kang, M; Paik, SW; Guallar, E; Cho, J; Gwak, GY
PLoS One 2019 10.1371/journal.pone.0213547
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW
KOREAN J RADIOL 2019 10.3348/kjr.2018.0339
Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images
Kim1, M; Kang, TW; Cha, DI; Jang, KM; Kim, YK; Kim, SH; Sinn, DH; Kim, K
J CLIN GASTROENTEROL 2019 10.1097/MCG.0000000000000987
Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors
Yoon1, EL; Kim, TY; Lee, CH; Kim, TH; Cho, HC; Lee, SS; Kim, SE; Kim, HY; Kim, CW; Song, DS; Yang, JM; Sinn, DH; Jung, YK; Yim, HJ; Kim, HS; Sohn, JH; Kim, JH; Choe, WH; Lee, BS; Kim, MY; Jeong, SW; Choi, E; Kim, DJ
EUR RADIOL 2019 10.1007/s00330-018-5617-6
Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications
Kim1, R; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH
PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
ANN SURG 2018 10.1097/SLA.0000000000002318
Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors
Han1, S; Yang, JD; Sinn, DH; Kim, JM; Choi, GS; Jung, G; Ahn, JH; Kim, S; Ko, JS; Gwak, MS; Kwon, CHD; Leise, MD; Gwak, GY; Heimbach, JK; Kim, GS
EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
LIVER TRANSPLANT 2018 10.1002/lt.25307
Laparoscopic Donor Hepatectomy for Adult Living Donor Liver Transplantation Recipients
Kwon1, CHD; Choi, GS; Kim, JM; Cho, CW; Rhu, J; Kim, GS; Sinn, DH; Joh, JW
J CLIN MICROBIOL 2018 10.1128/JCM.00438-18
Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients
Ryu1, MR; Park, MS; Cho, EH; Jung, CW; Kim, K; Kim, SJ; Oh, HY; Huh, W; Jang, HR; Koh, WJ; Park, HY; Kim, YH; Sinn, DH; Choi, JO; Joh, JW; Kim, JM; Kim, SJ; Park, JB; Kang, ES
TRANSPLANTATION 2018 10.1097/TP.0000000000002154
ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence
Kim1, JM; Kwon, CHD; Joh, JW; Han, S; Yoo, J; Kim, K; Sinn, DH; Choi, GS; Gerber, DA; Egawa, H; Lee, SK
RADIOLOGY 2018 10.1148/radiol.2018172743
Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes
Song1, KD; Lee, MW; Rhim, H; Kang, TW; Cha, DI; Sinn, DH; Lim, HK
Abdom Radiol (NY) 2018 10.1007/s00261-018-1480-9
Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance
Min1, JH; Kim, YK; Sinn, DH; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Kim, MJ
ANN SURG TREAT RES 2018 10.4174/astr.2018.95.3.147
Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
Kim1, JM; Lee, KW; Sinn, DH; Choi, GS; Yi, NJ; Kwon, CHD; Suh, KS; Joh, JW
LIVER INT 2018 10.1111/liv.13732
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW
CLIN RADIOL 2018 10.1016/j.crad.2018.02.007
Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes
Min1, JH; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Sinn, DH; Kim, JM; Sohn, I
J HEPATOL 2018 10.1016/j.jhep.2018.02.026
Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes
Lee1, S; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Kim, JM; Kim, K
SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
J HEPATOL 2018 10.1016/j.jhep.2018.01.024
Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma
Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ
SCI REP-UK 2018 10.1038/s41598-018-25628-w
Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria
Kim1, YR; Park, S; Han, S; Ahn, JH; Kim, S; Sinn, DH; Jeong, WK; Ko, JS; Gwak, MS; Kim, GS
J GASTROEN HEPATOL 2018 10.1111/jgh.14042
Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study
Min1, YW; Kim, Y; Gwak, GY; Gu, S; Kang, D; Cho, SJ; Guallar, E; Cho, J; Sinn, DH
DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
ANN SURG TREAT RES 2018 10.4174/astr.2018.94.4.183
Prognosis of preoperative positron emission tomography uptake in hepatectomy patients
Kim1, JM; Kwon, CHD; Joh, JW; Sinn, DH; Choi, GS; Paik, SW
J GASTROEN HEPATOL 2018 10.1111/jgh.13991
Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure
Song1, DS; Kim, TY; Kim, DJ; Kim, HY; Sinn, DH; Yoon, EL; Kim, CW; Jung, YK; Suk, KT; Lee, SS; Lee, CH; Kim, TH; Choe, WH; Yim, HJ; Kim, SE; Baik, SK; Jang, JY; Kim, HS; Kim, SG; Yang, JM; Sohn, JH; Choi, EH; Cho, HC; Jeong, SW; Kim, MY
SCI REP-UK 2018 10.1038/s41598-018-23014-0
Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study
Jang1, HR; Kang, D; Sinn, DH; Gu, S; Cho, SJ; Lee, JE; Huh, W; Paik, SW; Ryu, S; Chang, Y; Shafi, T; Lazo, M; Guallar, E; Cho, J; Gwak, GY
LIVER INT 2018 10.1111/liv.13489
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
CLIN IMAG 2018 10.1016/j.clinimag.2017.08.004
The qualitative and quantitative image analysis of MR imaging in patients with acute-on-chronic liver failure
Kang1, TW; Kim, M; Kim, YK; Kim, SH; Sinn, DH; Kim, K
J HEPATOL 2017
Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study
Sinn1, DH; Kang, D; Jang, HR; Gu, S; Cho, SJ; Paik, SW; Ryu, S; Chang, Y; Lazo, M; Guallar, E; Cho, J; Gwak, GY
J INFECT DIS 2017 10.1093/infdis/jix506
Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study
Chang1, Y; Choe, WH; Sinn, DH; Lee, JH; Ahn, SH; Lee, H; Shim, JJ; Jun, DW; Park, SY; Nam, JY; Cho, EJ; Yu, SJ; Lee, DH; Lee, JM; Kim, YJ; Kwon, SY; Paik, SW; Yoon, JH
DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8
Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
J GASTROENTEROL 2017 10.1007/s00535-017-1337-y
A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease
Kim1, TJ; Sinn, DH; Min, YW; Son, HJ; Kim, JJ; Chang, Y; Baek, SY; Ahn, SH; Lee, H; Ryu, S
SCI REP-UK 2017 10.1038/s41598-017-13501-1
Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomas
Lee1, HM; Joh, JW; Seo, SR; Kim, WT; Kim, MK; Choi, HS; Kim, SY; Jang, YJ; Sinn, DH; Choi, GS; Kim, JM; Kwon, CHD; Chang, HJ; Kim, DS; Ryu, CJ
J HEPATOL 2017 10.1016/j.jhep.2017.04.024
Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma
Lee1, S; Kim, SH; Lee, JE; Sinn, DH; Park, CK
EUR RADIOL 2017 10.1007/s00330-016-4662-2
Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants
Kim1, M; Kang, TW; Jeong, WK; Kim, YK; Kim, SH; Kim, JM; Sinn, DH; Kim, MJ; Jung, SH
ONCOTARGET 2017 10.18632/oncotarget.17072
Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
Yu1, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW
HEPATOLOGY 2017 10.1002/hep.28916
Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2016.096
Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
Cho1, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH
GUT LIVER 2017 10.5009/gnl16403
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647.
Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
CLINICAL RADIOLOGY, FEB 2017, 72(2):141-149, DOI: 10.1016/j.crad.2016.09.008
Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma
Kim SS1, Kang TW, Song KD, Cho SK, Lee MW, Rhim H, Sinn DH, Jung SH
Aliment Pharmacol Ther. 2017 Feb;45(4):577-578. doi: 10.1111/apt.13911.
Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia - authors' reply
Ahn JS11, Sinn DH1, Son HJ1,2, Gwak GY1.
Gut. 2017 Feb;66(2):323-329. doi: 10.1136/gutjnl-2016-311854. Epub 2016 Sep 6.
Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
Sinn DH11, Kang D2, Chang Y3,4,5, Ryu S3,4,5, Gu S6, Kim H6, Seong D2, Cho SJ7, Yi BK2,8, Park HD9, Paik SW1, Song YB1,10, Lazo M10, Lima JA10, Guallar E10, Cho J2,3,5,10, Gwak GY1.
Aliment Pharmacol Ther. 2017 Jan;45(2):345-353. doi: 10.1111/apt.13866. Epub 2016 Nov 18.
Non-alcoholic fatty liver diseases and risk of colorectal neoplasia
Ahn JS11, Sinn DH1, Min YW1, Hong SN1, Kim HS2, Jung SH2, Gu S3, Rhee PL1, Paik SW1, Son HJ4, Gwak GY1.
World J Gastroenterol. 2016 Nov 7;22(41):9205-9213.
Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis
Kim HY11, Kim CW1, Kim TY1, Song DS1, Sinn DH1, Yoon EL1, Jung YK1, Suk KT1, Lee SS1, Lee CH1, Kim TH1, Kim JH1, Yim HJ1, Kim SE1, Baik SK1, Lee BS1, Jang JY1, Kim YS1, Kim SG1, Yang JM1, Sohn JH1, Lee HJ1, Park SH1, Choi EH1, Kim DJ1; Korean Acute-on-Chronic Liver Failure Study Group.
Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527.
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Kim JH11, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19.
Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
PLoS One. 2016 Nov 15;11(11):e0165722. doi: 10.1371/journal.pone.0165722. eCollection 2016.
Survival Analysis of Single Large (> 5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
Cho Y11,2, Sinn DH3, Yu SJ1, Gwak GY3, Kim JH4, Yoo YJ4, Jun DW5, Kim TY6, Lee HY5, Cho EJ1, Lee JH1, Kim YJ1, Yoon JH1.
Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24.
The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM11, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.
Gastroenterology. 2016 Sep;151(3):481-488.e1. doi: 10.1053/j.gastro.2016.06.001. Epub 2016 Jun 7.
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn DH11, Cho SJ2, Gu S3, Seong D4, Kang D5, Kim H6, Yi BK7, Paik SW1, Guallar E8, Cho J8, Gwak GY9.
Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368.
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
Lee K11, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Transplantation. 2016 Sep;100(9):1933-8. doi: 10.1097/TP.0000000000001293.
Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence
Han S11, Yang JD, Sinn DH, Ko JS, Kim JM, Shin JC, Son HJ, Gwak MS, Joh JW, Kim GS.
Ann Surg. 2016 Aug;264(2):339-43. doi: 10.1097/SLA.0000000000001486.
Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma
Han S11, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, Lee SK, Gwak MS.
Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735.
Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study
Kim JH11, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026.
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.
Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25.
Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial
Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
JOURNAL OF KOREAN MEDICAL SCIENCE, MAY 2016, 31(5):825-826, DOI: 10.3346/jkms.2016.31.5.825
Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase Response
Lee J1, Sinn DH, Paik SW
Cardiovasc Intervent Radiol. 2016 Apr;39(4):620-3. doi: 10.1007/s00270-015-1222-0. Epub 2015 Oct 30.
Portal Vein Stenting for Portal Biliopathy with Jaundice
Hyun D11, Park KB2, Lim SJ3, Hwang JH4, Sinn DH5.
World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785.
Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease
Hong YS11, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155.
Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
Ahn JM11, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
Liver Transpl. 2016 Feb;22(2):209-16. doi: 10.1002/lt.24336.
Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study
Kim JM11, Kwon CH1, Joh JW1, Sinn DH2, Lee S1, Choi GS1, Lee SK1.
Br J Surg. 2016 Feb;103(3):276-83. doi: 10.1002/bjs.10048. Epub 2015 Dec 23.
Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation
Kim JM11, Kwon CH1, Joh JW1, Han SB2, Sinn DH3, Choi GS1, Kang ES4, Lee JH3, Kim GS2, Lee SK1.
Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718.
Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods
Kim JM11, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.
Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578.
Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
Sinn DH11, Cho SJ, Gwak GY, Cho J, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW.
PLoS One. 2016 Jan 20;11(1):e0146745. doi: 10.1371/journal.pone.0146745. eCollection 2016.
Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition
Kim TY11, Song do S2, Kim HY2, Sinn DH3, Yoon EL4, Kim CW2, Jung YK5, Suk KT6, Lee SS7, Lee CH8, Kim TH9, Kim JH10, Choe WH10, Yim HJ5, Kim SE11, Baik SK12, Lee BS13, Jang JY14, Suh J 3rd15, Kim HS16, Nam SW17, Kwon HC17, Kim YS18, Kim SG18, Chae HB19, Yang JM2, Sohn JH20, Lee HJ21, Park SH22, Han BH23, Choi EH24, Kim CH25, Kim DJ6; Korean Acute-on-Chronic Liver Failure Study Group.
Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28.
Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors
Kim HJ11, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015.
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
Ahn JM11,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Medicine (Baltimore). 2015 Nov;94(44):e1771. doi: 10.1097/MD.0000000000001771.
Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications A Prospective Pilot Study
Kim JM11, Joh JW, Kim HJ, Kim SH, Rha M, Sinn DH, Choi GS, Kwon CH, Cho YY, Suh JM, Lee SK.
Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12.
Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy
Lee JY11, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.
J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16.
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
Lee J11, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3.
Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
Sinn DH11, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
J Viral Hepat. 2015 Jun;22(6):539-50. doi: 10.1111/jvh.12356. Epub 2014 Nov 7.
Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load
Sohn W11, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
PLoS One. 2015 May 5;10(5):e0123554. doi: 10.1371/journal.pone.0123554. eCollection 2015.
Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
Kim JM11, Kwon CH1, Joh JW1, Ha YE2, Sinn DH3, Choi GS1, Peck KR2, Lee SK1.
J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13.
Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors
Sohn W11, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015.
Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
Sinn DH11, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
World J Gastroenterol. 2015 Mar 28;21(12):3587-92. doi: 10.3748/wjg.v21.i12.3587.
Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia
Park H11, Jang KJ1, Jang W1, Park SH1, Park JY1, Jeon TJ1, Oh TH1, Shin WC1, Choi WC1, Sinn DH1.
Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11.
Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women
Sinn DH11, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90.
Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses
Huang CS1, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.
Medicine (Baltimore). 2015 Feb;94(6):e450. doi: 10.1097/MD.0000000000000450.
Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy A Matched Study
Kim JM11, Kwon CH, Joh JW, Sinn DH, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
PLoS One. 2014 Nov 5;9(11):e112184. doi: 10.1371/journal.pone.0112184. eCollection 2014.
Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
Sinn DH11, Gwak GY1, Cho J2, Paik SW1, Yoo BC1.
Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2.
A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma
Shin JU11, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.
Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21.
Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease
Sinn DH11, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.
Transplantation. 2013 Jun 15;95(11):1404-9. doi: 10.1097/TP.0b013e31828d1588.
Steatosis Among Living Liver Donors Without Evidence of Fatty Liver on Ultrasonography: Potential Implications for Preoperative Liver Biopsy
Ahn JS11, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
J Gastroenterol Hepatol. 2010 Mar;25(3):539-43. doi: 10.1111/j.1440-1746.2009.06108.x.
Change in cross-sectional area of esophageal muscle does not correlate with the outcome of achalasia after pneumatic balloon dilatation
Sinn DH11, Choi YS, Kim JH, Kim ER, Son HJ, Kim JJ, Rhee JC, Rhee PL.
Hepatogastroenterology.?2009 May-Jun;56(91-92):672-6.
Effectiveness of Each Bethesda Marker in Defining Microsatellite Instability when Screening for Lynch Syndrome
Sinn DH11,?Chang DK,?Kim YH,?Rhee PL,?Kim JJ,?Kim DS,?Park CK,?Kim JW,?Yun SH,?Lee WY,?Chun HK,?Rhee JC.
Liver Int. 2008 Dec;28(10):1363-9. doi: 10.1111/j.1478-3231.2008.01860.x.
Disease progression and the risk factor analysis for chronic hepatitis C
Sinn DH11, Paik SW, Kang P, Kil JS, Park SU, Lee SY, Song SM, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC.
Dig Dis Sci.?2008 Oct;53(10):2714-8. doi: 10.1007/s10620-007-0196-4. Epub 2008 Feb 15.
Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome
Sinn DH11,?Song JH,?Kim HJ,?Lee JH,?Son HJ,?Chang DK,?Kim YH,?Kim JJ,?Rhee JC,?Rhee PL.
Aliment Pharmacol Ther.?2008 Jun;27(12):1275-81. doi: 10.1111/j.1365-2036.2008.03659.x. Epub 2008 Feb 27.
Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus
Sinn DH11,?Kim JH,?Kim S,?Son HJ,?Kim JJ,?Rhee JC,?Rhee PL.